HIF1-α upregulates immunomodulatory surface ligands such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), inhibiting efficient anti-tumor immune responses [101]. This evidence concerns the gene CTLA4 and neoplasm.